Search clinical trials for: LactiSal vaginal gel 1%

Total 364 results

Università degli Studi dell'Insubria

Unknown

Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis

Vaginitis

Italy
BioClin BV
Avania

Recruiting

Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

Bacterial Vaginoses

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel

Completed

Efficacy and Safety of Non-hormonal Vaginal Preparations in Treating Vaginal Dryness

Vaginal Dryness

Germany
Medinova AG

Withdrawn

Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis

Vulvovaginal Candidiasis
Procare Health Iberia S.L.
Adknoma Health Research

Completed

Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV. (PAPILOBS)

HPV Infection | Lesion Cervix

Spain
Procare Health Iberia S.L.
Adknoma Health Research

Completed

Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV (PALOMA)

Human Papilloma Virus Infection | Human Papilloma Virus | Cervix Lesion

Spain
CONRAD

Withdrawn

Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females

HIV Prevention

United States
Elpen Pharmaceutical Co. Inc.

Completed

Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR). (PAPILOBSGR)

Papillomavirus Infections

Greece
Procare Health Iberia S.L.
Adknoma Health Research

Active, not recruiting

Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. (PALOMA2)

Human Papilloma Virus Infection | Human Papilloma Virus | Cervix Lesion

Spain
Assiut University

Completed

Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis (MNZ)

Vaginitis
CONRAD
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

HIV Prevention

United States
Biosyn
United States Agency for International Development (USAID); FHI 360

Unknown

Trial of SAVVY Vaginal Gel and HIV in Nigeria

HIV Infections

Nigeria
Sarawak General Hospital

Not yet recruiting

Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause (VHAL)

Sexual Dysfunction | Atrophic Vaginitis | Menopause Related Conditions | Genitourinary Syndrome of Menopause
Biosyn
United States Agency for International Development (USAID); FHI 360

Unknown

Trial of SAVVY and HIV in Ghana

HIV Infections

Ghana
University of Washington
Gilead Sciences; CONRAD

Completed

Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding

Herpes Simplex Type II

United States
Ospedale Policlinico San Martino

Completed

HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period (HYDEAL-D)

Sexual Dysfunction | Vagina; Anomaly | Puerperium; Disease

Italy
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); The Miriam Hospital and other collaborators

Completed

Optical Imaging and User Perception Study of Vaginal Gel

Characterize Gel Distribution in the Vagina | Study Women's Sensory Perceptions and Preferences of Gel

United States
HAN Biomedical Inc

Completed

Evaluation of the Efficacy and Safety of A High Molecular Weight, Natural Hyaluronic Acid Vaginal Gel in Women With Genitourinary Syndrome of Menopause

Menopause Syndrome

Taiwan
University of Sao Paulo

Unknown

Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women

Sexual Dysfunction | Menopause | Dyspareunia

Brazil
Zambon SpA

Completed

Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness

Vaginal Dryness

Italy
Laval University

Completed

Spermicidal Efficacy Of A Vaginal Gel

Contraception

Canada
Indiana University School of Medicine

Completed

Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial

Bacterial Vaginosis

United States
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

Acne Vulgaris

Australia
University Hospital, Antwerp

Completed

Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis

Candidiasis, Vulvovaginal
Juniper Pharmaceuticals, Inc.

Completed

Vaginal Progesterone to Reduce the Risk of Another Preterm Birth

Pregnancy

United States
Memorial Sloan Kettering Cancer Center

Completed

Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health

Breast Cancer | Endometrial Cancer

United States
Indiana University School of Medicine

Terminated

Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial

Cesarean Section | Surgical Wound Infection | Endometritis

United States
Starpharma Pty Ltd

Completed

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

Recurrent Bacterial Vaginosis (BV)
Ruhr University of Bochum

Recruiting

DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections (HPV-VG1)

HPV Infection | Cervix Dysplasia

Germany
Bitop AG

Completed

Non-Interventional Multicentre Post-market Study of Ectoin® Vaginal Gel for Symptomatic Treatment of Vaginal Atrophy (EIC01-PMCF)

Vaginal Atrophy

Germany
CONRAD

Completed

Contraceptive Effectiveness Trial of Cellulose Sulfate Gel

Contraception

United States
Vaginal Biome Science
Vaginal Biome Science

Completed

Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome

Bacterial Vaginosis

United States
The Miriam Hospital
National Institute of Allergy and Infectious Diseases (NIAID); ImQuest Pharmaceuticals...

Completed

A Formative Study to Explore the Sensory Perceptions of Vaginal Product Users (Project-MIST)

Microbicide Delivery System Acceptability

United States
Novan, Inc.

Completed

A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

Acne Vulgaris

Dominican Republic, Honduras, Panama
Wake Forest University Health Sciences
Carolinas Medical Center

Completed

Sexual Absorption of Vaginal Progesterone

Infertility | Pregnancy

United States
CONRAD
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04 (FAME 04)

HIV

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463

Vaginal Infection

United States
CONRAD
RTI International; Match Research; UZ-UCSF Collaborative Research Programme

Completed

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

HIV | Contraception

South Africa, Zimbabwe
Ian McGowan
National Institute of Allergy and Infectious Diseases (NIAID); CONRAD

Completed

An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations

HIV Prevention

United States
International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium

HIV Infections
Aswan University Hospital

Not yet recruiting

Developmental Endothelial Locus-1, Platelet Count, and Soluble P-selectin in Overweight and Obese Subjects

Overweight and Obesity

Egypt
Daré Bioscience, Inc.

Completed

DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)

Bacterial Vaginosis

United States
International Partnership for Microbicides, Inc.

Completed

Assessing the Safety of Dapivirine Gel and Film Formulations

HIV Infections

United States
CONRAD

Completed

Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms

HIV

United States
Memorial Sisli Hospital, Istanbul

Unknown

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles

Drug Effect | Infertility, Female | Dydrogesterone | Infertility, Male | Reproductive Techniques, Assisted | Progesterone | Embryo Transfer | Fertilization in Vitro

Turkey
DermBiont, Inc.

Recruiting

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Non-Melanoma Skin Cancers

United States
Ian McGowan
National Institute of Allergy and Infectious Diseases (NIAID); CONRAD

Completed

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

HIV Prevention

United States
University Hospital Center of Martinique

Completed

Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor (GELFREQ)

Labor Complication | Cervix

Martinique
University of Calgary
Juniper Pharmaceuticals, Inc.; Calgary Health Region

Completed

Vaginal Progesterone Versus Placebo in Multiple Pregnancy

Preterm Birth

Canada
Prism Pharma Co., Ltd.

Completed

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Systemic Scleroderma

United States

Search clinical trials for: LactiSal vaginal gel 1%

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations